Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
about
p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistanceJC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?Extracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH)Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplificationKu proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cellsY-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.Prognostic association of YB-1 expression in breast cancers: a matter of antibody.Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESsYB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis.Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1Integrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate.Phosphatidylinositol 3-Kinase dependent upregulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells.Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancerEpstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.Prognostic role of YB-1 expression in breast cancer: a meta-analysisImpact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.YB-1 drives preneoplastic progression: Insight into opportunities for cancer preventionAUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cells.Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancerGenome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiformeYB-1, the E2F pathway, and regulation of tumor cell growth.YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene ExpressionRedefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cellsCombining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management.Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma.EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean.Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapySerum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis.
P2860
Q21261313-A4F4AD22-A26F-4BC2-BE60-6539BEA3EC47Q24634312-9AE1D054-A26B-427A-BB13-D35130C022ACQ27006654-BD47BE78-93B7-400C-9D7F-85B854F0183BQ30352429-F4C8BD6A-3ED6-4181-995C-50F80A86FF91Q30908486-6D48D9DE-5F9D-4BDE-81DF-0C8CCBC6E89CQ33292142-53433C24-02B2-4852-B436-B8D876A296F1Q33627164-90CB0391-3419-436F-9BB1-77C1E73D5E39Q33628528-1006EB9A-FCA4-48FE-BCA4-9078EAA3C49DQ33766973-7AB4134A-44E8-408A-BE6D-08D52C26C428Q33906226-B42DBADB-E813-4C1A-B86C-DF5B80F2C89CQ33939605-A59C8468-C7D1-4E8A-8D74-BB11BDB63C1BQ33972424-C7BD557A-EE0E-480A-99FF-93414763E8ADQ34007902-700103A9-06B6-4F12-8895-5F071AA4AF7CQ34078933-1D48C2DC-49B0-450D-9C3D-3BF254E4557EQ34117426-9108BFBD-E013-45A4-9180-B0A99BC77374Q34152071-61CE001D-E212-4CA8-B948-038F8BED7808Q34430583-3534033C-C748-4714-B673-D8835C3FB9BAQ34484279-E3500D8D-866E-4C8F-BD18-7A90FC1289C3Q34530534-2BD21D3D-38E9-426A-B547-C975602F1EBCQ34934082-1139D2C3-4ABA-4427-8275-C255FD6D55FDQ35063920-0729C5BE-029F-408E-904B-56A9C5BDE171Q35238430-98B615B4-DDA1-421E-95CC-C1B33FACA79CQ35479413-A83F3F3D-026F-4808-B691-CF0FF9C8162AQ35558949-32146FE6-0806-40AD-9186-76B7CEDA6739Q35640233-73D4BF9F-8C25-4CF9-ADB2-88A7C36F19CFQ35733747-0A49FD7E-AF93-4613-83AA-661F5E6F72F0Q36458742-62E22AAF-A5E2-4A47-84E3-21033A536420Q36507592-5FB2855D-8885-4D0B-97AF-07A4508F8AB1Q36676735-07432EB4-85CD-46E7-9F0C-B0FA0F020F2EQ36755479-DED4B6A7-0636-42E8-917A-8045929E311FQ36791090-87141B23-01C4-47D1-9166-B6AB0D960071Q37038686-2DA93C70-EE05-4E17-99B6-FCEC3A963640Q37131331-2A3198FA-E261-4F2C-AA4B-FB9E70D3375EQ37134990-16CD180E-C89F-4BF0-A3B4-7613B7BE921BQ37195479-34566ACE-B976-4ABE-8A8A-AF9E8E73B26FQ37206247-6226615B-6FE7-46D2-AAD8-BA872CE5351BQ37208186-0051425D-FA9E-4ECE-9098-688DE4878EB4Q37467199-B85EFBD0-24F3-4A6A-9342-1807E0B1A3BDQ37627936-AA4E0E65-D68E-4100-9309-E13344DC6741Q37644894-203BC689-3D33-40CE-8FEC-823F7B549FEC
P2860
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Disruption of the Y-box bindin ...... wth factor receptor and HER-2.
@en
type
label
Disruption of the Y-box bindin ...... wth factor receptor and HER-2.
@en
prefLabel
Disruption of the Y-box bindin ...... wth factor receptor and HER-2.
@en
P2093
P1433
P1476
Disruption of the Y-box bindin ...... wth factor receptor and HER-2.
@en
P2093
C Blake Gilks
Daniel Yokom
Dmitry Turbin
Erika Yorida
Helen Jiang
Isabelle M Berquin
Maggie C U Cheang
Peter R Mertens
P304
P356
10.1158/0008-5472.CAN-05-3561
P407
P577
2006-05-01T00:00:00Z